Dr. David Malkin and his team of researchers at The Hospital for Sick Children (aka, “SickKids”) will receive $2.2 million over the next three years. The team has been working to find better ways to predict the type and age of onset of cancer in patients with LFS. Their ultimate goals are to develop a blood test that detects cancer earlier, and to identify treatments to prevent cancer from developing in patients who are at risk.
